Published in Jpn J Ophthalmol on July 03, 2012
A functional variant of pre-miRNA-196a2 confers risk for Behcet's disease but not for Vogt-Koyanagi-Harada syndrome or AAU in ankylosing spondylitis. Hum Genet (2013) 0.86
Characteristics of uveitic glaucoma and evaluation of its surgical treatment. Clin Ophthalmol (2014) 0.85
Epidemiology of uveitis in the mid-Atlantic United States. Clin Ophthalmol (2015) 0.84
Behçet's disease ocular attack score 24: evaluation of ocular disease activity before and after initiation of infliximab. Jpn J Ophthalmol (2014) 0.84
Comparison of the ocular characteristics of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus. Jpn J Ophthalmol (2014) 0.82
A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases. Jpn J Ophthalmol (2016) 0.81
Pharmacotherapy for uveitis: current management and emerging therapy. Clin Ophthalmol (2014) 0.81
Incidence and clinical features of recurrent Vogt-Koyanagi-Harada disease in Japanese individuals. Jpn J Ophthalmol (2015) 0.79
A functional variant of PTPN22 confers risk for Vogt-Koyanagi-Harada syndrome but not for ankylosing spondylitis. PLoS One (2014) 0.79
Diagnostic efficacy of cell block method for vitreoretinal lymphoma. Diagn Pathol (2016) 0.78
Acute retinal necrosis: factors associated with anatomic and visual outcomes. Jpn J Ophthalmol (2012) 0.78
Correlation between Ocular Manifestations and Their Complications as Opposed to Visual Acuity and Treatment in Behcet's Disease. Autoimmune Dis (2013) 0.77
The microbiome, HLA, and the pathogenesis of uveitis. Jpn J Ophthalmol (2015) 0.77
Behcet's disease: systemic and ocular manifestations. Biomed Res Int (2013) 0.77
Copy number variants and genetic polymorphisms in TBX21, GATA3, Rorc, Foxp3 and susceptibility to Behcet's disease and Vogt-Koyanagi-Harada syndrome. Sci Rep (2015) 0.77
Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis (2016) 0.76
Clinical features of human T lymphotropic virus type 1-associated uveitis in Hokkaido, Japan. Jpn J Ophthalmol (2013) 0.76
A Rare Case of Unilateral Progressive Vision Loss and Pachymeningitis. Neuroophthalmology (2016) 0.75
Vogt-Koyanagi-Harada syndrome - current perspectives. Clin Ophthalmol (2016) 0.75
Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: A case report. Medicine (Baltimore) (2017) 0.75
Prediction of severe cardiac involvement by fundus lesion in sarcoidosis. Jpn J Ophthalmol (2013) 0.75
Uveitis profile and treatment response in Iranian patients with sarcoidosis. Int Ophthalmol (2014) 0.75
[Update: Behçet's disease]. Z Rheumatol (2012) 0.75
Tubulointerstitial nephritis and uveitis (TINU) syndrome: a systematic review of its epidemiology, demographics and risk factors. Orphanet J Rare Dis (2017) 0.75
Uveitis incidence in Jichi Medical University Hospital, Japan, during 2011-2015. Clin Ophthalmol (2017) 0.75
Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol (2001) 5.62
Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol (2007) 1.84
Uveitis: a global perspective. Ocul Immunol Inflamm (2002) 1.62
Comparison of patients with Behçet's disease in the 1980s and 1990s. Ophthalmology (2004) 1.16
HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol (1994) 1.10
Acute anterior uveitis and HLA-B27 subtypes. Invest Ophthalmol Vis Sci (1988) 0.89
Human leukocyte antigen A29 subtypes associated with birdshot retinochoroidopathy. Am J Ophthalmol (2004) 0.87
Clinical statistics of endogenous uveitis: comparison between general eye clinic and university hospital. Int Ophthalmol (2010) 0.79
[Diagnostic Guidelines and Criteria for Sarcoidosis--2006]. Nihon Kokyuki Gakkai Zasshi (2008) 0.76
Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis. J Rheumatol (2004) 3.28
Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet (2010) 2.74
Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol (2003) 2.58
Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol (2002) 2.49
Prevalence and characteristics of foveal retinal detachment without macular hole in high myopia. Am J Ophthalmol (2003) 2.47
International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm (2009) 2.47
Spontaneous closure of traumatic macular hole. Am J Ophthalmol (2002) 2.00
Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease. Br J Ophthalmol (2009) 1.91
The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J Leukoc Biol (2003) 1.84
Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol (2007) 1.84
Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology (2003) 1.78
Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease. Eur Heart J (2010) 1.74
Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood (2010) 1.57
The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J Clin Invest (2005) 1.56
Long-term pattern of progression of myopic maculopathy: a natural history study. Ophthalmology (2010) 1.51
A genome-wide association analysis identified a novel susceptible locus for pathological myopia at 11q24.1. PLoS Genet (2009) 1.43
Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest Ophthalmol Vis Sci (2006) 1.41
Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am J Ophthalmol (2002) 1.40
Natural course of macular retinoschisis in highly myopic eyes without macular hole or retinal detachment. Am J Ophthalmol (2006) 1.38
Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. Int Immunol (2007) 1.36
Characteristics of peripapillary detachment in pathologic myopia. Arch Ophthalmol (2006) 1.34
Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease. Arthritis Res Ther (2012) 1.34
Clearance of apoptotic photoreceptors: elimination of apoptotic debris into the subretinal space and macrophage-mediated phagocytosis via phosphatidylserine receptor and integrin alphavbeta3. Am J Pathol (2003) 1.30
Detection of Candida and Aspergillus species DNA using broad-range real-time PCR for fungal endophthalmitis. Graefes Arch Clin Exp Ophthalmol (2011) 1.30
Clinical characteristics of posterior staphyloma in eyes with pathologic myopia. Am J Ophthalmol (2008) 1.30
Long-term visual prognosis of choroidal neovascularization in high myopia: a comparison between age groups. Ophthalmology (2002) 1.29
CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site. J Immunol (2003) 1.25
Use of a comprehensive polymerase chain reaction system for diagnosis of ocular infectious diseases. Ophthalmology (2013) 1.25
Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis. Rheumatology (Oxford) (2009) 1.25
Presumed Vogt-Koyanagi-Harada disease with unilateral ocular involvement: report of three cases. Graefes Arch Clin Exp Ophthalmol (2009) 1.23
A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol (2002) 1.22
Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis. Invest Ophthalmol Vis Sci (2006) 1.22
Peripapillary changes detected by optical coherence tomography in eyes with high myopia. Ophthalmology (2007) 1.21
Detection of paravascular lamellar holes and other paravascular abnormalities by optical coherence tomography in eyes with high myopia. Ophthalmology (2007) 1.21
Gene transfer to corneal epithelium and keratocytes mediated by ultrasound with microbubbles. Invest Ophthalmol Vis Sci (2006) 1.19
Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2002) 1.18
Preparation and characterization of decellularized cornea using high-hydrostatic pressurization for corneal tissue engineering. Biomaterials (2010) 1.18
Bone marrow-derived stem cells can differentiate into retinal cells in injured rat retina. Stem Cells (2002) 1.17
Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy. J Clin Endocrinol Metab (2007) 1.16
Prognosis of canine patients with nasal tumors according to modified clinical stages based on computed tomography: a retrospective study. J Vet Med Sci (2008) 1.15
Reduced retinal angiogenesis in MMP-2-deficient mice. Invest Ophthalmol Vis Sci (2003) 1.14
Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor. Invest Ophthalmol Vis Sci (2009) 1.14
Long-term changes in axial length in adult eyes with pathologic myopia. Am J Ophthalmol (2010) 1.12
Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells. Biochem Biophys Res Commun (2003) 1.12
Diagnosis of intraocular lymphoma by polymerase chain reaction analysis and cytokine profiling of the vitreous fluid. Jpn J Ophthalmol (2009) 1.11
Tailor-made tricalcium phosphate bone implant directly fabricated by a three-dimensional ink-jet printer. J Artif Organs (2006) 1.10
IL-23-independent induction of IL-17 from γδT cells and innate lymphoid cells promotes experimental intraocular neovascularization. J Immunol (2013) 1.08
Work-up, diagnosis and management of acute Vogt-Koyanagi-Harada disease: a case of acute myopization with granulomatous uveitis. Int Ophthalmol (2007) 1.08
Fundus characteristics of high myopia in children. Jpn J Ophthalmol (2005) 1.08
Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology (2009) 1.06
In vivo evaluation of a novel scaffold for artificial corneas prepared by using ultrahigh hydrostatic pressure to decellularize porcine corneas. Mol Vis (2009) 1.06
The eye's view of antigen presentation. Hum Immunol (2002) 1.05
Diagnosis of bacterial endophthalmitis by broad-range quantitative PCR. Br J Ophthalmol (2010) 1.05
The CD4/CD8 ratio in vitreous fluid is of high diagnostic value in sarcoidosis. Ophthalmology (2012) 1.04
Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice. Graefes Arch Clin Exp Ophthalmol (2003) 1.04
Characteristics of patients with a favorable natural course of myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (2004) 1.04
Retinal pigment epithelium-derived CTLA-2alpha induces TGFbeta-producing T regulatory cells. J Immunol (2008) 1.03
Trehalose treatment suppresses inflammation, oxidative stress, and vasospasm induced by experimental subarachnoid hemorrhage. J Transl Med (2012) 1.03
Identification of human herpesvirus 6 in a patient with severe unilateral panuveitis. Arch Ophthalmol (2007) 1.03
Relationship between serum infliximab levels and acute uveitis attacks in patients with Behcet disease. Br J Ophthalmol (2010) 1.03
Functional expression of B7H1 on retinal pigment epithelial cells. Exp Eye Res (2007) 1.02
Simultaneous analysis of multiple cytokines in the vitreous of patients with sarcoid uveitis. Invest Ophthalmol Vis Sci (2012) 1.02
Tomographic image and visual recovery of acute macula-off rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol (2004) 1.02
Protection of human corneal epithelial cells from TNF-α-induced disruption of barrier function by rebamipide. Invest Ophthalmol Vis Sci (2013) 1.02
Fundus autofluorescence patterns in eyes with primary intraocular lymphoma. Retina (2010) 1.02
Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization. Invest Ophthalmol Vis Sci (2003) 1.01
MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner. Biochem Biophys Res Commun (2009) 1.01
Quantitative evaluation of ischemia-reperfusion injury by optical coherence tomography in the rat retina. Jpn J Ophthalmol (2005) 1.01
Two patients with severe corneal disease in KID syndrome. Am J Ophthalmol (2004) 1.01
Retromode retinal imaging of macular retinoschisis in highly myopic eyes. Am J Ophthalmol (2010) 1.01
Multicenter study of infliximab for refractory uveoretinitis in Behçet disease. Arch Ophthalmol (2012) 1.01
Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy. Am J Ophthalmol (2009) 1.00
T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions. Invest Ophthalmol Vis Sci (2009) 0.99
Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells. Invest Ophthalmol Vis Sci (2006) 0.99
A significant association of viral loads with corneal endothelial cell damage in cytomegalovirus anterior uveitis. Br J Ophthalmol (2009) 0.99
Amyloid-beta up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: Another mechanism of complement activation in age-related macular degeneration. J Cell Physiol (2009) 0.99
Absence of association between COL1A1 polymorphisms and high myopia in the Japanese population. Invest Ophthalmol Vis Sci (2008) 0.99
Evaluation of characteristic ocular signs and systemic investigations in ocular sarcoidosis patients. Jpn J Ophthalmol (2007) 0.98
Induction of regulatory T cells by infliximab in Behcet's disease. Invest Ophthalmol Vis Sci (2011) 0.97
Choroidal neovascularization enhanced by Chlamydia pneumoniae via Toll-like receptor 2 in the retinal pigment epithelium. Invest Ophthalmol Vis Sci (2010) 0.97
Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy. Retina (2010) 0.97
Phacoemulsification cataract extraction and intraocular lens implantation in patients with uveitis. J Cataract Refract Surg (2007) 0.96
Reduction of retinal blood flow in high myopia. Graefes Arch Clin Exp Ophthalmol (2004) 0.96
Relation of intraocular concentrations of inflammatory factors and improvement of macular edema after vitrectomy in branch retinal vein occlusion. Am J Ophthalmol (2011) 0.95
Autofluorescence of metastatic choroidal tumor. Int Ophthalmol (2008) 0.95
Association of 15q14 and 15q25 with high myopia in Japanese. Invest Ophthalmol Vis Sci (2011) 0.95
Inhibition of melanoma by ultrasound-microbubble-aided drug delivery suggests membrane permeabilization. Cancer Biol Ther (2007) 0.95
Interleukin-18 regulates pathological intraocular neovascularization. J Leukoc Biol (2007) 0.95
The role of soluble TNF receptors for TNF-alpha in uveitis. Invest Ophthalmol Vis Sci (2007) 0.95
Detection of paravascular retinal cysts before using OCT in a highly myopic patient. Graefes Arch Clin Exp Ophthalmol (2005) 0.95
Photodynamic therapy with verteporfin for choroidal neovascularization of pathologic myopia in Japanese patients: comparison with nontreated controls. Am J Ophthalmol (2008) 0.95
Diagnosis of ocular sarcoidosis. Ocul Immunol Inflamm (2010) 0.94
Photophobia in essential blepharospasm--a positron emission tomographic study. Mov Disord (2010) 0.94
Leukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathy. Mol Vis (2007) 0.94
Pharmacokinetics of fentanyl after single intravenous injection and constant rate infusion in dogs. Vet Anaesth Analg (2006) 0.94
Development of macular hole and macular retinoschisis in eyes with myopic choroidal neovascularization. Am J Ophthalmol (2007) 0.94